Secor Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-21,524
Closed -$1.67M 580
2018
Q1
$1.67M Buy
+21,524
New +$1.73M 0.14% 234
2016
Q3
Sell
-8,933
Closed -$704K 599
2016
Q2
$704K Sell
8,933
-16,370
-65% -$1.23M 0.09% 308
2016
Q1
$1.82M Buy
+25,303
New +$1.91M 0.25% 80
2015
Q4
Sell
-6,175
Closed -$517K 589
2015
Q3
$517K Buy
+6,175
New +$521K 0.16% 219

Other funds holding LLY

Secor Capital Advisors's LLY Position: Q2 2018 in Review

Secor Capital Advisors sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 21,524 shares — an estimated $1.67M sold.

Secor Capital Advisors first reported a position in LLY in Q3 2015 and held it in 4 quarters. The position peaked at $1.82M in Q1 2016. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • Secor Capital Advisors reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
  • Secor Capital Advisors sold 21,524 Eli Lilly shares in Q2 2018, an estimated $1.67M.
  • Secor Capital Advisors first reported a position in Eli Lilly in Q3 2015 and held it in 4 quarters.
  • Secor Capital Advisors's Eli Lilly position peaked at $1.82M in Q1 2016.
  • 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on Secor Capital Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.